Algorae Pharmaceuticals Limited has released a press release.
Patent application over AI-116 for Dementia filed
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- LCT Announces Shortfall Completion Notice
- Rights Issue Prospectus
- APeT Cleansing Announcement
- Pause in Trading
- LCT Undertakes $2.5 Million Capital Raise Initiative
Later from Algorae Pharmaceuticals
- Quarterly Activities/Appendix 4C Cash Flow Report
- LCT commences AI-116 pre clinical studies
- Quarterly Activities/Appendix 5B Cash Flow Report
- CSIRO Grant for Artificial Intelligence Platform
- Addendum to September Quarterly Report
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals